Solitary plasmocytoma occurring in bone (solitary plasmocytoma of the bone, SBP) or in soft tissue (extramedullary plasmocytoma, EP) can be treated effectively and with little toxicity by local radiotherapy. Ten-year local control rates of up to 90% can be achieved. Patients with multiple myeloma often suffer from symptoms such as pain or neurological impairments that are amenable to palliative radiotherapy. In a palliative setting, short treatment schedules and lower radiation doses are used to reduce toxicity and duration of hospitalization. In future, low-dose total body irradiation (TBI) may play a role in a potentially curative regimen with nonmyeloablative conditioning followed by allogenic peripheral blood stem cell transplantation. © 2011 Springer-Verlag.
CITATION STYLE
Krause, S., Debus, J., & Neuhof, D. (2011). Radiotherapy. Recent Results in Cancer Research. https://doi.org/10.1007/978-3-540-85772-3_13
Mendeley helps you to discover research relevant for your work.